+ A
A -
Tribune News Network
Doha
The Ministry of Public Health (MoPH) has added Covaxin developed by India’s Bharat Biotech to the list of Conditionally Approved COVID-19 Vaccines within its Travel and Return Policy. The approval comes into immediate effect.
Two doses of Sinopharm, Sinovac, Sputnik V and Covaxin are the conditionally approved vaccines that MoPH has included.
Serology Antibody test with a positive result is mandatory before travelling to Qatar for people with two doses of a conditionally approved vaccines and 14 days after the second dose, in which case only the traveler will be considered fully immune.
On November 3, the World Health Organization granted emergency approval for the “Covaxin” vaccine, which is the first vaccine to be fully developed and manufactured in India, and the eighth on the list of global vaccines approved to combat the coronavirus. The vaccine is 78 percent effective and recommended for all age groups, starting from the age of 18, and is given in two doses separated by four weeks, according to a statement issued by the WHO.
Doha
The Ministry of Public Health (MoPH) has added Covaxin developed by India’s Bharat Biotech to the list of Conditionally Approved COVID-19 Vaccines within its Travel and Return Policy. The approval comes into immediate effect.
Two doses of Sinopharm, Sinovac, Sputnik V and Covaxin are the conditionally approved vaccines that MoPH has included.
Serology Antibody test with a positive result is mandatory before travelling to Qatar for people with two doses of a conditionally approved vaccines and 14 days after the second dose, in which case only the traveler will be considered fully immune.
On November 3, the World Health Organization granted emergency approval for the “Covaxin” vaccine, which is the first vaccine to be fully developed and manufactured in India, and the eighth on the list of global vaccines approved to combat the coronavirus. The vaccine is 78 percent effective and recommended for all age groups, starting from the age of 18, and is given in two doses separated by four weeks, according to a statement issued by the WHO.
